Publications
Peer-reviewed articles, manuscripts in progress, and conference presentations.
Peer-reviewed articles
DNA Methylation in Glioblastoma: Insights from Single-Cell Epigenomics.
Epigenomics, 2026. doi:10.1080/17501911.2026.2682246
From Aberrant Transcripts to Clinical Applications: The Era of RNA-Seq in Rare Disease Diagnosis.
Clinical Chemistry — accepted, 2026.
Manuscripts under review
The Multifaceted Role of NEK7: Mitosis, Inflammation, and Cancer Immunopathology.
Cancer Cell International — under review, 2025.
Manuscripts in preparation
Population-Stratified ceRNA Network Analysis Reveals Distinct Regulatory Axes and Druggable Targets in African American and European American Prostate Cancer.
In preparation.
Conference presentations
Precision diagnosis in early-onset prostate cancer: a machine learning and transcriptomic approach identifies PCSEAT lncRNA as a race-specific biomarker.
E-Poster (EP17.007), European Human Genetics Conference (ESHG 2025), Milan, Italy, May 2025.
Decoding Glioblastoma Treatment Responses: A Combined Bioinformatics and Machine Learning Study.
Oral presentation, 2nd International Congress of Cancer Genomics (CGC2024), Tehran, Iran, October 2024.
★ Best Oral Presentation Award
Identifying hsa-miR-17-3p as a Potential Biomarker in Prostate Cancer Patients' Body Fluids Using Bioinformatics Tools.
6th International & 18th Iranian Genetics Congress, Tehran, Iran, 2024.
Differentiation of Glioblastoma Multiforme Solid and Recurrent Tumors Using Gene Expression Profile and Machine Learning Algorithms.
3rd International & 12th National Iranian Conference on Bioinformatics, February 2024.
Prediction of Prognosis in Glioblastoma Patients Treated with Chemotherapy and Radiotherapy Using Genomic SNV Profile.
6th International & 18th Iranian Genetics Congress, Tehran, Iran, 2024.